Paper Review Records
All Paper Review Records
28 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Emerging Targeted Therapies in Hidradenitis Suppurativa: A Systematic Review of JAK ‐1, IL ‐1, and CXCR1 /2 Pathway‐Directed Therapies
Jonathan Nakad; Manisha Kumar; Cindy Kok; John Frew; Tara SholjiShow moreShow less
1. The Skin Hospital Darlinghurst and Westmead New South Wales AustraliaShow moreShow less
Incidental Germline EPHB4 Variant in TEK ‐Related Venous Malformation
Ruo Yin Linda Liu; Danica Xie; Orli Wargon; Clara Chung; Artiene TatianShow moreShow less
1. Randwick Clinical Campus of the UNSW School of Clinical Medicine Sydney New South Wales Australia; 2. Department of Dermatology Sydney Children's Hospital Sydney New South Wales Australia; 3. School of Women's and Children's Health, UNSW Medicine UNSW Sydney Sydney New South Wales Australia; 4. Department of Clinical Genetics Sydney Children's Hospital Sydney New South Wales AustraliaShow moreShow less
Sun Exposure Is Associated With the Increase in Skin Cancer Numbers Over Time: The Trends of Skin CAncer Numbers in Solid Organ Transplant Recipients, TOSCANI Longitudinal Cohort Study
Anne Tseng; Ruby Chia‐Lin Lee; Charlotte Cox; Maria‐Celia Hughes; Lea Dousset; Susan Brown; Lena Von Schuckmann; Stuart MacGregor; Anthony Griffin; Scott Campbell; Nicole Isbel; Peter Hopkins; Daniel C. Chambers; Upekha Liyanage; Louisa Collins; H. Peter Soyer; Kiarash KhosrotehraniShow moreShow less
1. Frazer Institute, Dermatology Research Centre, Experimental Dermatology Group The University of Queensland Brisbane Queensland Australia; 2. Department of Dermatology Princess Alexandra Hospital Brisbane Queensland Australia; 3. QIMR‐Berghofer Medical Research Centre Brisbane Queensland Australia; 4. Princess Alexandra Hospital, Queensland Kidney Transplant Service Brisbane Queensland Australia; 5. School of Medicine The University of Queensland Brisbane Queensland Australia; 6. Prince Charles Hospital, Lung Transplantation Services Brisbane Queensland Australia; 7. Cancer Council Queensland Brisbane Queensland AustraliaShow moreShow less
Dual Biologic Therapy With Dupilumab and Mepolizumab in Refractory Atopic Dermatitis and Severe Eosinophilic Asthma
Lachlan D. W. Lau; Anthony Moussa; Mittal Patel; Celestine C. WongShow moreShow less
1. Department of Dermatology Royal Melbourne Hospital Parkville Victoria Australia; 2. Department of Immunology and Allergy Royal Melbourne Hospital Parkville Victoria Australia; 3. Department of Medicine University of Melbourne Parkville Victoria Australia; 4. Department of Dermatology Monash Health Clayton Victoria AustraliaShow moreShow less
Acute Cutaneous Kava Toxicity: A Multicentre Case Series From South Australia
Zoe Lee; Kristian Stefani; Karolina Kerkemeyer; Annabel StevensonShow moreShow less
1. College of Medicine and Public Health Flinders University Adelaide South Australia Australia; 2. Department of Dermatology Flinders Medical Centre Adelaide South Australia Australia; 3. Department of Dermatology Royal Adelaide Hospital Adelaide South Australia Australia; 4. Department of Dermatology Queen Elizabeth Hospital Woodville South South Australia Australia; 5. Faculty of Health and Medical Sciences University of Adelaide Adelaide South Australia AustraliaShow moreShow less
Real‐World Outcomes of Rituximab in Pemphigus: An Australian Tertiary Cohort
Pokphazz Christjaroon; Ali Abid; Orli Wargon; Paul Weller; Artiene TatianShow moreShow less
1. Department of Dermatology Sydney Children's Hospital Randwick New South Wales Australia; 2. Faculty of Medicine and Health University of New South Wales Sydney New South Wales Australia; 3. Department of Dermatology Liverpool Hospital Liverpool New South Wales AustraliaShow moreShow less
FAQ
How long does AUSTRALASIAN JOURNAL OF DERMATOLOGY take to review a manuscript?
As of 2026-11-17, CrushSCI has 28 complete review records for AUSTRALASIAN JOURNAL OF DERMATOLOGY. The fastest paper went from submission to acceptance in 3 days (Fatal Phenobarbital‐Associated Toxic Epidermal Necrolysis With Severe Acute Kidney Injury and Multiorgan Failure: Prognostic Value of SCORTEN and ALDEN, received 2026-06-20, accepted 2026-06-23); the slowest took 453 days. The average is 134.0 days and the median is 137 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
